Phase 3 Cognitive Decline Clinical Trials
5 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–5 of 5 trials
Recruiting
Phase 3
Biomarker Exploration in Aging, Cognition and Neurodegeneration
Cognitive ImpairmentCognitive DeclineAlzheimer Disease
University of California, Irvine300 enrolled1 locationNCT03860857
Recruiting
Phase 3
Polypill and RiscOMeter to Prevent StrOke and CogniTive ImpairmEnt (PROMOTE)
Cognitive DeclineStroke
Hospital Moinhos de Vento8,518 enrolled2 locationsNCT05155137
Recruiting
Phase 3
Preventing Alzheimer's With Cognitive Training
Age-related Cognitive DeclineAlzheimer's Disease and Related Dementias
University of South Florida7,600 enrolled7 locationsNCT03848312
Recruiting
Phase 2Phase 3
GnRH Therapy on Cognition in Down Syndrome
Cognitive DeclineAlzheimer Disease, Early OnsetDown Syndrome+1 more
Nelly Pitteloud56 enrolled1 locationNCT04390646
Terminated
Phase 3
Action To promote brain HEalth iN Adults (ATHENA) trial: a pilot feasibility study to determine the effects of blood pressure lowering treatment provided by a Triple Pill strategy for attenuation of cognitive decline in participants at risk for dementia.
Cognitive ImpairmentCognitive DysfunctionHypertension+1 more
The George Institute for Global Health200 enrolled1 locationACTRN12621000121864